Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing…
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing…
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing…
Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing…
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees…
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical…
Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by…
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in…
BOSTON, Sept. 16, 2025 /PRNewswire/ -- Q2i today announced a collaboration with King's College London (King's) to evaluate its AI-powered…
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Haven House Sober Living has been nominated for Best…